Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma. [electronic resource]
Producer: 19961009Description: 1254-6 p. digitalISSN:- 0959-8049
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Aspartic Acid -- administration & dosage
- Fluorouracil -- administration & dosage
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Middle Aged
- Phosphonoacetic Acid -- administration & dosage
- Recombinant Proteins
- Stomach Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.